Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Rheumatoid Arthritis

  Free Subscription


Articles published in Z Rheumatol

Retrieve available abstracts of 89 articles:
HTML format



Single Articles


    July 2024
  1. GULCEMAL MO, Sarac DC, Alp G, Duran G, et al
    Effects of video-based cervical stabilization home exercises in patients with rheumatoid arthritis: a randomized controlled pilot study.
    Z Rheumatol. 2024 Jul 1. doi: 10.1007/s00393-024-01543.
    PubMed     Abstract available


    June 2024
  2. KAMPEN WU, Bohuslavizki KH
    [When should patients with rheumatoid arthritis be treated with radiosynoviorthesis (RSO)?].
    Z Rheumatol. 2024 Jun 26. doi: 10.1007/s00393-024-01533.
    PubMed    


  3. LEE YH, Song GG
    All-cause and cause-specific mortality in rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2024 Jun 25. doi: 10.1007/s00393-024-01538.
    PubMed     Abstract available


  4. ERNST D, Kruger K, Witte T
    [Head-to-head trials in rheumatoid arthritis].
    Z Rheumatol. 2024 Jun 3. doi: 10.1007/s00393-024-01517.
    PubMed     Abstract available


    April 2024
  5. SCHULTZ O, Fiehn C, Kneitz C, Picker N, et al
    Real-world experience with filgotinib for rheumatoid arthritis in Germany : A retrospective chart review.
    Z Rheumatol. 2024 Apr 30. doi: 10.1007/s00393-024-01506.
    PubMed     Abstract available


  6. ZEHRFELD N, Witte T, Ernst D
    [Update on Sjogren's syndrome : Diagnostics, treatment, and challenges].
    Z Rheumatol. 2024;83:217-228.
    PubMed     Abstract available


  7. SCHNEIDEREIT T, Delia D, Schmeiser T, Buehring B, et al
    [The effect of intensified training therapy on axial spondylarthritis in day care units].
    Z Rheumatol. 2024;83:210-216.
    PubMed     Abstract available


  8. LEIPE J, Schmelz R, Riemekasten G, Thaci D, et al
    [Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].
    Z Rheumatol. 2024;83:200-209.
    PubMed     Abstract available


    March 2024
  9. KILTZ U, Wiatr T, Kiefer D, Baraliakos X, et al
    [Effect of multimodal rheumatologic complex treatment in patients with axial spondylarthritis : A systematic evaluation with standardized outcome parameters, such as the ASAS Health Index].
    Z Rheumatol. 2024;83:153-159.
    PubMed     Abstract available


    February 2024
  10. SANDIKCI SC, Gultuna S, Ozisler C, Aydin FN, et al
    The role of orexin in fatigue and sleep quality in patients with primary Sjogren's syndrome.
    Z Rheumatol. 2024;83.
    PubMed     Abstract available


  11. FIEHN C, Leipe J, Weseloh C, Bergner R, et al
    Assessment of interactions and dosage recommendations of synthetic DMARDs-Evidence-based and consensus-based recommendations based on a systematic literature search.
    Z Rheumatol. 2024;83.
    PubMed     Abstract available


  12. SEIFERT O, Baerwald C
    Stimulation of the vagus nerve as a therapeutic principle.
    Z Rheumatol. 2024;83.
    PubMed     Abstract available


  13. ALBRECHT K, Binder S, Minden K, Poddubnyy D, et al
    Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.
    Z Rheumatol. 2024;83.
    PubMed     Abstract available


  14. ISIK AC, Kavas M, Tezcan ME
    Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.
    Z Rheumatol. 2024;83.
    PubMed     Abstract available


    January 2024
  15. HACKNER K, Hutter L, Flick H, Grohs M, et al
    Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement.
    Z Rheumatol. 2024 Jan 19. doi: 10.1007/s00393-023-01464.
    PubMed     Abstract available


    December 2023
  16. MAKUS B, Rose T
    [Relapsing polychondritis].
    Z Rheumatol. 2023;82:867-876.
    PubMed     Abstract available


  17. HOLZAPFEL DE, Thieme M, Kappenschneider T, Holzapfel S, et al
    [Outcome of joint replacement in patients with underlying rheumatoid disease].
    Z Rheumatol. 2023;82:825-833.
    PubMed     Abstract available


  18. FREUDENBERG LS, Baraliakos X, Kampen WU, Vereb M, et al
    [Pain reduction by radiosynoviorthesis in rheumatism-induced synovitis of the elbow : Results of a retrospective multicenter data analysis].
    Z Rheumatol. 2023;82:892-897.
    PubMed     Abstract available


    November 2023
  19. ALBRECHT K, Binder S, Minden K, Poddubnyy D, et al
    [Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version].
    Z Rheumatol. 2023;82:727-738.
    PubMed     Abstract available


    October 2023
  20. QIN Y, Su J
    Salidroside suppresses cell growth and inflammatory response of fibroblast-like synoviocytes via inhibition of phosphoinositol-3 kinase/threonine kinase signaling in rheumatoid arthritis.
    Z Rheumatol. 2023 Oct 18. doi: 10.1007/s00393-023-01431.
    PubMed     Abstract available


  21. HOFFMANN T, Teichgraber U, Lassen-Schmidt B, Kroegel C, et al
    [Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis?].
    Z Rheumatol. 2023 Oct 17. doi: 10.1007/s00393-023-01434.
    PubMed     Abstract available


  22. PETERS J, Timme-Bronsert S, Voll RE, Finzel S, et al
    [Salivary gland ultrasound or biopsy? : Comparison of methods based on case examples].
    Z Rheumatol. 2023;82:654-665.
    PubMed     Abstract available


    September 2023
  23. YU T, Yang C
    Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis.
    Z Rheumatol. 2023 Sep 27. doi: 10.1007/s00393-023-01430.
    PubMed     Abstract available


    August 2023
  24. HOEPER JR, Schuch F, Steffens-Korbanka P, Gauler G, et al
    [Delegation of medical duties to qualified rheumatology assistants : Effect on depression and anxiety in patients with rheumatoid arthritis].
    Z Rheumatol. 2023 Aug 30. doi: 10.1007/s00393-023-01403.
    PubMed     Abstract available


  25. SEIFERT O, Baerwald C
    [Stimulation of the vagus nerve as a therapeutic principle. German Version].
    Z Rheumatol. 2023;82:462-471.
    PubMed     Abstract available


  26. STRAUB RH, Pongratz G, Buttgereit F, Gaber T, et al
    [Energy metabolism of the immune system : Consequences in chronic inflammation].
    Z Rheumatol. 2023;82:479-490.
    PubMed     Abstract available


  27. JAKOBS M, Hadamitzky M, Schedlowski M, Heiss-Luckemann L, et al
    [Conditioning of the immune system-Already clinically usable?].
    Z Rheumatol. 2023;82:472-478.
    PubMed     Abstract available


    June 2023
  28. BIRKNER B, Rech J, Edelmann E, Verheyen F, et al
    Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis.
    Z Rheumatol. 2023 Jun 23. doi: 10.1007/s00393-023-01380.
    PubMed     Abstract available


  29. LEE YH, Song GG
    Comparison of the efficacy and safety of olokizumab at different dosages in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2023 Jun 2. doi: 10.1007/s00393-023-01367.
    PubMed     Abstract available


  30. STRUNZ PP, Schmalzing M
    [This is how I treat patients who need DMARD treatment and have MGUS].
    Z Rheumatol. 2023;82:404-407.
    PubMed    


  31. LEE YH, Song GG
    Relative efficacy and safety of Janus kinase inhibitors for the treatment of active psoriatic arthritis: a network meta-analysis.
    Z Rheumatol. 2023;82:408-416.
    PubMed     Abstract available


    May 2023
  32. ARINGER M, Koschel D, Dorner T, Sewerin P, et al
    [Practicable diagnostics of Sjogren's syndrome in interstitial lung disease-A discussion article].
    Z Rheumatol. 2023;82:321-324.
    PubMed     Abstract available


    April 2023
  33. KRUGER K
    [DMARD (disease-modifying antirheumatic drug) treatment in patients with former or current cancer].
    Z Rheumatol. 2023;82:206-211.
    PubMed     Abstract available


  34. KRUGER K
    [Must folic acid and folinic acid be substituted in methotrexate treatment? If yes, how much?].
    Z Rheumatol. 2023;82:246-247.
    PubMed    


    March 2023
  35. FIEHN C, Leipe J, Weseloh C, Bergner R, et al
    [Assessment of interactions and dosage recommendations of synthetic DMARDs-Evidence-based and consensus-based recommendations based on a systematic literature search].
    Z Rheumatol. 2023;82:151-162.
    PubMed     Abstract available


  36. VORDENBAUMEN S, Feist E
    [Adult-onset Still's disease : Diagnosis and treatment according to the new S2e guidelines of the German Society of Rheumatology (DGRh)].
    Z Rheumatol. 2023;82:134-142.
    PubMed     Abstract available


  37. RATH E, Bonelli M, Duftner C, Gruber J, et al
    [National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMA
    Z Rheumatol. 2023;82:163-174.
    PubMed     Abstract available


  38. BARALIAKOS X, Alshakaki F, Buhring B, Andreica I, et al
    [How many patients with inflammatory rheumatic diseases have the technical prerequisites for video consultations and are also willing to use this to carry out visits by medical specialist visits?].
    Z Rheumatol. 2023;82:102-107.
    PubMed     Abstract available


    February 2023
  39. DE GROOT K, Schreiber JG
    [This is how I treat rheumatoid arthritis in dialysis patients].
    Z Rheumatol. 2023 Feb 28. doi: 10.1007/s00393-023-01334.
    PubMed    


  40. FIEHN C, Zinke S, Haas JS, Meise D, et al
    Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis.
    Z Rheumatol. 2023 Feb 9. doi: 10.1007/s00393-023-01323.
    PubMed     Abstract available


  41. VORDENBAUMEN S, Feist E, Rech J, Fleck M, et al
    Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline.
    Z Rheumatol. 2023;82.
    PubMed    


    January 2023
  42. HO LEE Y, Gyu Song G
    Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2023 Jan 6. doi: 10.1007/s00393-022-01315.
    PubMed     Abstract available


  43. NIEDERMANN K, Rausch AK, Braun J, Becker H, et al
    [Lay version of the 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis : Translation into German and linguistic validation in German-speaking countries with people affected].
    Z Rheumatol. 2023;82.
    PubMed     Abstract available


  44. SIEIRO SANTOS C, Moriano Morales C, Alvarez Castro C, Diez Alvarez E, et al
    Polyautoimmunity in systemic lupus erythematosus: secondary Sjogren syndrome.
    Z Rheumatol. 2023;82.
    PubMed     Abstract available


    December 2022
  45. VORDENBAUMEN S, Feist E, Rech J, Fleck M, et al
    [DGRh S2e guidelines : Diagnostic and treatment of adult-onset Still's disease (AOSD)].
    Z Rheumatol. 2022;81.
    PubMed    


  46. VORDENBAUMEN S, Feist E, Rech J, Fleck M, et al
    [Guideline report on the DGRh S2e guidelines on diagnostics and treatment of adult-onset Still's disease (AOSD)].
    Z Rheumatol. 2022;81.
    PubMed    


    November 2022
  47. LEE YH, Song GG
    Relative effectiveness and safety of interleukin-6 and Janus kinase inhibitors versus adalimumab in patients with rheumatoid arthritis: a network meta-analysis.
    Z Rheumatol. 2022 Nov 24. doi: 10.1007/s00393-022-01290.
    PubMed     Abstract available


  48. BRUYN GA, Wong P
    The Genesis of Sjogren.
    Z Rheumatol. 2022;81:787-791.
    PubMed     Abstract available


  49. RUBBERT-ROTH A
    [ORAL SURVEILLANCE: what has changed in the risk assessment of JAK inhibitors?]
    Z Rheumatol. 2022;81:780-781.
    PubMed    


    October 2022
  50. MARKER-HERMANN E
    [Renal manifestations in rheumatoid arthritis and spondylarthritis].
    Z Rheumatol. 2022 Oct 20. pii: 10.1007/s00393-022-01279.
    PubMed     Abstract available


    September 2022
  51. TRIANTAFYLLIAS K, Sauer C, Schwarting A
    [Therapeutic effects of complex multimodal rheumatologic treatment in the Rheumatology Center, Rhineland-Palatinate].
    Z Rheumatol. 2022;81:596-604.
    PubMed     Abstract available


    August 2022
  52. ALBRECHT K, Leipe J
    [Continue or interrupt? Antirheumatic treatment in elective surgery].
    Z Rheumatol. 2022;81:492-500.
    PubMed     Abstract available


  53. FIORI W, Lakomek HJ, Strunk J, Klemann A, et al
    [Rheumatologic inpatient treatment-more than a complex treatment : Data reflecting services and structures].
    Z Rheumatol. 2022;81:472-481.
    PubMed     Abstract available


    June 2022
  54. MISCHKEWITZ M, Alten R
    [This is how we treat rheumatoid nodules in patients with rheumatoid arthritis in remission].
    Z Rheumatol. 2022 Jun 20. pii: 10.1007/s00393-022-01228.
    PubMed    


  55. ALBRECHT K, Marschall U, Zink A, Callhoff J, et al
    [Prescription frequency of physical therapy for inflammatory rheumatic diseases].
    Z Rheumatol. 2022;81:360-368.
    PubMed     Abstract available


    May 2022
  56. ZHANG G, Liu W, Zhang X, Liu L, et al
    Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
    Z Rheumatol. 2022;81:335-338.
    PubMed     Abstract available


    April 2022
  57. BEIL FT
    [What are the indications for a synovectomy?]
    Z Rheumatol. 2022;81:236-239.
    PubMed     Abstract available


    March 2022
  58. ALBRECHT K, Callhoff J, Strangfeld A
    [Is the prevalence of rheumatoid arthritis truly on the rise?]
    Z Rheumatol. 2022 Mar 31. pii: 10.1007/s00393-022-01192.
    PubMed     Abstract available


  59. MEISSNER Y, Strangfeld A
    [Latest findings from the RABBIT register].
    Z Rheumatol. 2022;81:100-109.
    PubMed     Abstract available


  60. WITTE T
    [Janus kinase inhibitors].
    Z Rheumatol. 2022;81:94-99.
    PubMed     Abstract available


  61. BRAUN J, Richter A, Schmidt C, Baraliakos X, et al
    [Answering epidemiologic rheumatologic questions by cooperation with the large population-based SHIP cohort-findings with relevance for the diagnosis of axial spondyloarthritis (axSpA)].
    Z Rheumatol. 2022;81:150-156.
    PubMed     Abstract available


  62. SHENG Z, Zeng J, Huang W, Li L, et al
    Comparison of therapeutic efficacy and mechanism of paclitaxel alone or in combination with methotrexate in a collagen-induced arthritis rat model.
    Z Rheumatol. 2022;81:164-173.
    PubMed     Abstract available


  63. ALBRECHT K, Kruger K
    [New aspects on treatment of RA].
    Z Rheumatol. 2022;81:91-93.
    PubMed    


    February 2022
  64. LEE YH, Song GG
    Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis.
    Z Rheumatol. 2022 Feb 10. pii: 10.1007/s00393-022-01165.
    PubMed     Abstract available


  65. REGEL A, Foll D, Kriegel MA
    [Still's syndrome-similarities and differences between the juvenile and adult forms].
    Z Rheumatol. 2022;81:22-27.
    PubMed     Abstract available


    January 2022
  66. KRUGER K
    [Innovative strategies for treatment of rheumatoid arthritis].
    Z Rheumatol. 2022 Jan 7. pii: 10.1007/s00393-021-01144.
    PubMed     Abstract available


    December 2021
  67. RUFFER N, Tomas NM, Schmiedel S, Jordan S, et al
    [Erratum to: Visceral leishmaniasis mimicking Felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept].
    Z Rheumatol. 2021 Dec 21. pii: 10.1007/s00393-021-01143.
    PubMed    


  68. WITTE F, Lakomek HJ, Holzinger J, Reinbold WD, et al
    [Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis].
    Z Rheumatol. 2021 Dec 1. pii: 10.1007/s00393-021-01133.
    PubMed     Abstract available


  69. KNAB K, Chambers D, Kronke G
    [Protective macrophages : New insights into the role of synovial macrophages in inflammatory joint diseases].
    Z Rheumatol. 2021;80:966-971.
    PubMed     Abstract available


    November 2021
  70. MORF H, Witte T
    [Use of biosimilars in the treatment of rheumatoid arthritis : An overview].
    Z Rheumatol. 2021 Nov 26. pii: 10.1007/s00393-021-01129.
    PubMed     Abstract available


  71. SUNG YK, Lee YH
    The lessebo effect in randomized controlled trials of rituximab in patients with rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2021 Nov 10. pii: 10.1007/s00393-021-01126.
    PubMed     Abstract available


  72. KLEINERT S
    [Data analysis in rheumatology practices : Possibilities, limitations, and results].
    Z Rheumatol. 2021;80:827-834.
    PubMed     Abstract available


    October 2021
  73. HAAS JP, Weimann V, Feist E
    [Polyarticular juvenile idiopathic arthritis and rheumatoid arthritis : Common features and differences].
    Z Rheumatol. 2021 Oct 28. pii: 10.1007/s00393-021-01114.
    PubMed     Abstract available


  74. KILTZ U, Buschhorn-Milberger V, Albrecht K, Lakomek HJ, et al
    [Development of quality standards for patients with rheumatoid arthritis for use in Germany].
    Z Rheumatol. 2021 Oct 15. pii: 10.1007/s00393-021-01093.
    PubMed     Abstract available


  75. RUFFER N, Tomas NM, Schmiedel S, Jordan S, et al
    [Visceral leishmaniasis mimicking Felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept].
    Z Rheumatol. 2021 Oct 11. pii: 10.1007/s00393-021-01105.
    PubMed     Abstract available


  76. LAKOMEK HJ, Rudwaleit M, Hentschel A, Broge B, et al
    [Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].
    Z Rheumatol. 2021;80:758-770.
    PubMed     Abstract available


    September 2021
  77. TEKAYA R, Rouached L, Ben Ahmed H, Ben Tekaya A, et al
    Variation of homocysteine levels in rheumatoid arthritis patients: relationship to inflammation, cardiovascular risk factors, and methotrexate.
    Z Rheumatol. 2021 Sep 27. pii: 10.1007/s00393-021-01092.
    PubMed     Abstract available


  78. MAO YM, Liao T, Ye QL, Wu GC, et al
    Increased circulating sclerostin levels in rheumatoid arthritis patients: an updated meta-analysis.
    Z Rheumatol. 2021 Sep 20. pii: 10.1007/s00393-021-01091.
    PubMed     Abstract available


  79. PARDEY N, Zeidler J, Nellenschulte TF, Stahmeyer JT, et al
    [Methotrexate treatment before use of biologics in rheumatoid arthritis : Analysis of guideline compliance].
    Z Rheumatol. 2021 Sep 20. pii: 10.1007/s00393-021-01086.
    PubMed     Abstract available


    July 2021
  80. SUNG YK, Lee YH
    Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-anal
    Z Rheumatol. 2021 Jul 9. pii: 10.1007/s00393-021-01047.
    PubMed     Abstract available


  81. LEE YH, Song GG
    Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 6. pii: 10.1007/s00393-021-01040.
    PubMed     Abstract available


  82. HO LEE Y, Gyu Song G
    Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 5. pii: 10.1007/s00393-021-01041.
    PubMed     Abstract available


    June 2021
  83. CHRISTENN M
    [Immunogenicity and safety of high dose vs. standard dose of inactivated influenza vaccine in patients with rheumatoid arthritis].
    Z Rheumatol. 2021 Jun 25. pii: 10.1007/s00393-021-01030.
    PubMed    


  84. VALOR-MENDEZ L, Manger B, Schett G, Kleyer A, et al
    [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].
    Z Rheumatol. 2021 Jun 7. pii: 10.1007/s00393-021-01020.
    PubMed     Abstract available


  85. SIEROCINSKI E, Angelow A, Mainz A, Walker J, et al
    [Patient safety in the treatment of rheumatic diseases : Laboratory monitoring in methotrexate treatment].
    Z Rheumatol. 2021;80:418-424.
    PubMed     Abstract available


    May 2021
  86. LEE YH, Song GG
    Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis.
    Z Rheumatol. 2021 May 17. pii: 10.1007/s00393-021-01013.
    PubMed     Abstract available


    April 2021
  87. ARTZT B, Arndt M, Wickler B, Rehart S, et al
    [Gigantic prepatellar "tumor" in rheumatoid arthritis-a case report].
    Z Rheumatol. 2021 Apr 30. pii: 10.1007/s00393-021-01010.
    PubMed     Abstract available


  88. ALBRECHT K, Zink A
    [If smoking, then also drinking? : New aspects on the influence of alcohol and smoking on the risk for rheumatoid arthritis].
    Z Rheumatol. 2021 Apr 20. pii: 10.1007/s00393-021-01004.
    PubMed    


  89. HARTUNG W, Sewerin P, Ostendorf B
    [Sports and exercise therapy in inflammatory rheumatic diseases].
    Z Rheumatol. 2021;80:251-262.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.